Dr. Michael Salvatore Conte, MD

Dr. Conte practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Conte's NPI, 1417993247, was assigned on June 21, 2006. Dr. Conte graduated from Albert Einstein College of Medicine in 1986. Dr. Conte holds California license G88336.

Dr. Conte's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Conte's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Conte is also affiliated with MarinHealth Medical Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Conte to 4 more group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Conte practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Conte's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Conte is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Conte's licenses on file in 3 states: California, Massachusetts and Connecticut.

Dmand AI lists aortic atherosclerois, arterial blot clot /embolism, carotid revascularization, chronic skin ulcer, circulatory problems in extremities, heart device and aorta surgery, leg revascularization and peripheral vascular disease among the conditions Dr. Conte treats.

CMS data shows 786 Medicare services from Dr. Conte across 15 procedure codes in 2024, for 582 Medicare patients. Medicare paid $35,818 for them.

CMS counts 582 Medicare patients who saw Dr. Conte in 2024. The largest group is 65 to 74, with 219 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Conte's median patient age at 71, with 44% women.

In 2024, Dr. Conte wrote 50 Medicare Part D claims for 20 patients. 90% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $31 in total drug cost. In 2023, CMS named 41 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Conte for performance year 2024, reported as part of a group. Dr. Conte accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Conte as offering telehealth. CMS counts 24 procedures of leg revascularization (restoring blood flow) by Dr. Conte, more than 84% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 290 papers to Dr. Conte, published from 2002 to 2025. 2020 was the busiest year, with 18. The most frequent topics are Peripheral Arterial Disease, Ischemia and Vascular Surgical Procedures. Dr. Conte has published most often in J Vasc Surg. Dr. Conte's most frequent co-authors are Michael Belkin, MD, Warren J. Gasper, MD and James Christopher Iannuzzi, MD.

Dmand AI links Dr. Conte to 7 clinical trials. Conditions studied include Peripheral Arterial Disease, Peripheral Vascular Diseases and Intermittent Claudication. University of California, San Francisco sponsors the most, 4. Open Payments lists research payments to Dr. Conte that name 1 trial.

CMS Open Payments shows 143 general payments to Dr. Conte from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 62% of the total. Abbott Laboratories paid the most, $17,274. It also lists 5 research payments totaling $133,391 from 2016 to 2024, naming 1 clinical trial.

Dmand AI lists 3 awards for Dr. Conte, most recently CMS Stage 1 EHR in 2013. Dr. Conte serves on Lower Extremity Guidelines Committee Society for Vascular Surgery.

Dr. Conte graduated from Albert Einstein College of Medicine in 1986. Dr. Conte is a member of ACS and SVS.

Dr. Conte is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.